Lamivudine treatment for acute severe hepatitis B: Report of a case and review of the literature

Acta Gastro-Enterologica Belgica

Volumn 71, Issue 1, 2008, Pages 30-32

  Roussos, Anastasios ^a,c   Koilakou, S ^a   Kalafatas, I ^a   Kalantzis, C ^b   Apostolou, N ^a   Grivas, E ^a   Raptis, N ^a   Mantzaris, G ^a  

^a EVANGELISMOS HOSPITAL   (Greece)

^b NMTS Hospital   (Greece)

^c NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ALPHA 1 ANTITRYPSIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CERULOPLASMIN; DNA; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LAMIVUDINE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CASE REPORT; CERULOPLASMIN BLOOD LEVEL; CHRONIC LIVER DISEASE; CYTOMEGALOVIRUS; ECHOGRAPHY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LEUKOCYTE DIFFERENTIAL COUNT; LIVER FAILURE; POLYMERASE CHAIN REACTION; SEROLOGY; THROMBOCYTE COUNT; VIROLOGY; VIRUS INFECTION;

ACUTE DISEASE; FEMALE; HEPATITIS B; HUMANS; LAMIVUDINE; LIVER FAILURE, ACUTE; MIDDLE AGED; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 42949099872     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. LETTAU L.A., MCCARTHY J.G., SMITH M.H., HADLER S.C., MORSE L.J., UKENA T., BESSETTE R., GURWITZ A., IRVINE W.G., FIELDS H.A. Outbreak of severe hepatitis due to delta and hepatitis B viruses in parenteral drug abusers and their contacts. N. Engl. J. Med., 1987, 317 (20): 1256-62.
2. TAKAHASHI Y., SHIMIZU M. Aetiology and prognosis of fulminant viral hepatitis in Japan : a multicentre study. The Study Group of Fulminant Hepatitis J. Gastroenterol. Hepatol., 1991, 6 : 159-64.
3. ACHARYA S.K., DASARATHY S., KUMER T.L., SUSHMA S., PRASANNA K.S., TANDON A., SREENIVAS V., NIJHAWAN S., PANDA S.K., NANDA S.K., IRSHAD M., JOSHI Y.K., DUTTAGUPTA S., TANDON R.K., TANDON B.N. Fulminant hepatitis in a tropical population : clinical course, cause, and early predictors of outcome. Hepatology, 1996, 23 : 1448-55.
4. MONTALTI R., NARDO B., BELTEMPO P., BERTELLI R., PUVIANI L., CAVALLARI A. Liver transplantation in fulminant hepatic failure : experience with 40 adult patients over a 17-year period. Transplant. Proc., 2005, 37 : 1085-7.
5. DIENSTAG J.L., PERRILLO R.P., SCHIFF E.R., BARTHOLOMEW M., VICARY C., RUBIN M. A preliminary trial of lamivudine for chronic hepatitis B infection. N. Engl. J. Med., 1995, 333 : 1657-61.
6. COIFFIER B. Hepatitis B virus reactivation in patients receiving chemotherapy for cancer treatment : role of Lamivudine prophylaxis Cancer Invest., 2006, 24 : 548-52.
7. ZHANG F.K. Lamivudine treatment of decompensated hepatitis B virus-related cirrhosis. Hepatobiliary Pancreat Dis. Int., 2006, 5 : 10-5.
8. KEEFFE E.B., DIETERICH D.T., HAN S.H. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States : an update. Clin. Gastroenterol. Hepatol., 2006, 4 : 936-62.
9. JACOBSON I.M. Therapeutic options for chronic hepatitis B : considerations and controversies. Am. J. Gastroenterol., 2006, 101 Suppl 1 : S13-8.
10. DIXON J.S., BOEHME R.E. Lamivudine for the treatment of chronic hepatitis B. Acta Gastroenterol. Belg., 2000, 63 (4) : 348-56.
11. AKYUZ F., KAYMAKOGLU S., DEMIR K., AKSOY N., KARACA C., DANALIOGLU A., ONEL D., BADUR S., BESISIK F., CAKALOGLU Y., OKTEN A. Lamivudine monotherapy and lamivudine plus interferon alpha combination therapy in HBeAg negative chronic hepatitis B not responding to previous interferon alpha monotherapy. Acta Gastroenterol. Belg., 2007, 70 : 20-4.
12. COLLE I., ADLER M., BRENARD R. et al. Management and treatment of chronic hepatitis B virus : Belgian Association for the Study of the Liver (BASL), 2007 guidelines. Acta Gastroenterol. Belg., 2007, 70 : 389-420.
13. SCHREIBMAN I.R., SCHIFF E.R. Prevention and treatment of recurrent Hepatitis B after liver transplantation : the current role of nucleoside and nucleotide analogues. Ann. Clin. Microbiol. Antimicrob., 2006, 6 : 5-8.
14. SANTANTONIO T., MAZZOLA M., PASTURE G. Lamivudine is safe and effective in fulminant hepatitis Br. J Hepatol., 1999, 30 : 551
15. RESHEF R., SBEIT W., TUR-KASPA R. Lamivudine in the treatment of acute hepatitis B. N. Engl. J. Med., 2000, 343 : 1123-4.
16. TORII N., HASEGAWA K., OGAWA M., HASHIMO E., HAYASHI N. Effectiveness and long-term outcome of lamivudine therapy for acute hepatitis B. Hepatol. Res., 2002, 24 : 34-41.
17. KONDILI L.A., OSMAN H., MUTIMER D. The use of lamivudine for patients with acute hepatitis B (a series of cases). J. Viral. Hepat., 2004, 11 : 427-31.
18. SCHMILOVITZ-WEISS H., BEN-ARI Z., SIKULER E., ZUCKERMAN E., SBEIT W., ACKERMAN Z., SAFADI R., LURIE Y., ROSNER G., TUR-KASPA R., RESHEF R. Lamivudine treatment for acute severe hepatitis B : a pilot study. Liver Int., 2004, 24 : 547-51.
19. TILLMANN H.L., HADEM J., LEIFELD L., ZACHOU K., CANBAY A., EISENBACH C., GRAZIADEI I., ENCKE J., SCHMIDT H., VOGEL W., SCHNEIDER A., SPENGLER U., GERKEN G., DALEKOS G.N., WEDEMEYER H., MANNS M.P. Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience. J. Viral. Hepat., 2006, 13 : 256-63.
20. KUMAR M., SATAPATHY S., MONGA R., DAS K., HISSAR S., PANDE C., SHARMA B.C., SARIN S.K. A randomized controlled trial of lamivudine to treat acute hepatitis B. Hepatology, 2007 Jan, 45 (1) : 97-101.
21. KIRSH B.M., LAM N., LAYDEN T.J., WILEY T.E. Diagnosis and management of fulminant hepatic failure. Compr. Ther., 1995, 21 : 166-71.
22. LEIFELD L., CHENG S., RAMAKERS J., DUMOULIN F.L., TRAUTWEIN C., SAUERBRUCH T., SPENGLER U. Imbalanced intrahepatic expression of interleukin 12, interferon gamma, and interleukin 10 in fulminant hepatitis B. Hepatology, 2002, 36 : 1001-8.